PTC124/Nonsense mutation Duchenne muscular dystrophy therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PTC124/Nonsense mutation Duchenne muscular dystrophy therapy, covering 2022-04-05 to 2022-04-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) [Phase 2]